Meeting
2022 ASCO Gastrointestinal Cancers Symposium
The role of genetic variants involved with ferroptosis regulator genes in predicting outcomes in patients (pts) with RAS-mutant metastatic colorectal cancer (mCRC): Data from MAVERICC and TRIBE trials.
Authors
Jingyuan Wang
Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA
Jingyuan Wang , Joshua Millstein , Hiroyuki Arai , Francesca Battaglin , Natsuko Kawanishi , Priya Jayachandran , Shivani Soni , Zhang Wu , Christoph Mancao , Chiara Cremolini , Volker Heinemann , Alfredo Falcone , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.197
Abstract #
197
Poster Bd #
K4
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Germline polymorphisms in genes maintaining replication fork to predict the efficacy of oxaliplatin and irinotecan in metastatic colorectal cancer (mCRC) patients enrolled in MAVERICC trial.
First Author: Hiroyuki Arai
Poster
2021 ASCO Annual Meeting
Genetic variants involved in the cGAS-STING pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and TRIBE trials.
First Author: Jingyuan Wang
Poster
2021 Gastrointestinal Cancers Symposium
Genetic variants involved in the lipid metabolism pathway to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and MAVERICC trials.
First Author: Jingyuan Wang
Poster
2021 ASCO Annual Meeting
The role of PP2A variants to predict outcome in patients (pts) with metastatic colorectal cancer (mCRC): Data from FIRE-3 and TRIBE trials.
First Author: Jingyuan Wang